BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15922918)

  • 1. Molecular events in tendinopathy: a role for metalloproteases.
    Magra M; Maffulli N
    Foot Ankle Clin; 2005 Jun; 10(2):267-77. PubMed ID: 15922918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
    De S; Fenton JE; Jones AS
    J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.
    Attia M; Huet E; Gossard C; Menashi S; Tassoni MC; Martelly I
    Am J Sports Med; 2013 Apr; 41(4):908-17. PubMed ID: 23404084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of matrix metalloproteinases and their tissue inhibitors in angiogenesis].
    Bogaczewicz J; Dudek W; Zubilewicz T; Wroński J; Przywara S; Chodorowska G; Krasowska D
    Pol Merkur Lekarski; 2006 Jul; 21(121):80-5. PubMed ID: 17007300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic tendon pathology: molecular basis and therapeutic implications.
    Riley G
    Expert Rev Mol Med; 2005 Mar; 7(5):1-25. PubMed ID: 15796783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of metalloproteinases and their tissular inhibitors in the processes of periodontal orthodontic remodeling.
    Surlin P; Rauten AM; Mateescu GO; Oprea B; Mariş M; Manolea H
    Rom J Morphol Embryol; 2009; 50(2):181-4. PubMed ID: 19434308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity.
    Dudhia J; Scott CM; Draper ER; Heinegård D; Pitsillides AA; Smith RK
    Aging Cell; 2007 Aug; 6(4):547-56. PubMed ID: 17578513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of matrix metalloproteinases in intestinal inflammation.
    Medina C; Radomski MW
    J Pharmacol Exp Ther; 2006 Sep; 318(3):933-8. PubMed ID: 16644899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
    Karthikeyan VJ; Lane DA; Beevers DG; Lip GY; Blann AD
    J Hum Hypertens; 2013 Feb; 27(2):72-8. PubMed ID: 22418748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP inhibition as a potential method to augment the healing of skeletal muscle and tendon extracellular matrix.
    Davis ME; Gumucio JP; Sugg KB; Bedi A; Mendias CL
    J Appl Physiol (1985); 2013 Sep; 115(6):884-91. PubMed ID: 23640595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression and matrix turnover in overused and damaged tendons.
    Riley GP
    Scand J Med Sci Sports; 2005 Aug; 15(4):241-51. PubMed ID: 15998341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J; Windsor LJ
    J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase inhibitors prevent a decrease in the mechanical properties of stress-deprived tendons: an in vitro experimental study.
    Arnoczky SP; Lavagnino M; Egerbacher M; Caballero O; Gardner K
    Am J Sports Med; 2007 May; 35(5):763-9. PubMed ID: 17293464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tissue inhibitors of metalloproteinases and matrix metalloproteinases on capsular formation around smooth and textured silicone gel implants.
    Ulrich D; Ulrich F; Pallua N; Eisenmann-Klein M
    Aesthetic Plast Surg; 2009 Jul; 33(4):555-62. PubMed ID: 19330370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.